These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17222742)

  • 1. Alpha2cDel322-325 and beta1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume.
    Canham RM; Das SR; Leonard D; Abdullah SM; Mehta SK; Chung AK; Li JL; Victor RG; Auchus RJ; Drazner MH
    J Am Coll Cardiol; 2007 Jan; 49(2):274-6. PubMed ID: 17222742
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.
    Small KM; Wagoner LE; Levin AM; Kardia SL; Liggett SB
    N Engl J Med; 2002 Oct; 347(15):1135-42. PubMed ID: 12374873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study.
    Metra M; Zani C; Covolo L; Nodari S; Pezzali N; Gelatti U; Donato F; Nardi G; Dei Cas L
    Eur J Heart Fail; 2006 Mar; 8(2):131-5. PubMed ID: 16188498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of adrenergic receptors and the risk of heart failure.
    Little J; Gwinn M; Khoury M
    N Engl J Med; 2003 Jan; 348(5):468-70; author reply 468-70. PubMed ID: 12557865
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic-receptor polymorphisms and heart failure.
    Hajjar RJ; MacRae CA
    N Engl J Med; 2002 Oct; 347(15):1196-9. PubMed ID: 12374881
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of the interaction of heritability of volume load and left ventricular mass: the HyperGEN offspring study.
    de Simone G; Tang W; Devereux RB; Hunt SC; Kitzman DW; Rao D; Arnett DK
    J Hypertens; 2007 Jul; 25(7):1397-402. PubMed ID: 17563561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population.
    Nonen S; Okamoto H; Akino M; Matsui Y; Fujio Y; Yoshiyama M; Takemoto Y; Yoshikawa J; Azuma J; Kitabatake A
    Br J Clin Pharmacol; 2005 Oct; 60(4):414-7. PubMed ID: 16187973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy.
    Reddy S; Fung A; Manlhiot C; Tierney ES; Chung WK; Blume E; Kaufman BD; Goldmuntz E; Colan S; Mital S
    Pediatr Res; 2015 Feb; 77(2):363-9. PubMed ID: 25406899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.
    Cresci S; Dorn GW; Jones PG; Beitelshees AL; Li AY; Lenzini PA; Province MA; Spertus JA; Lanfear DE
    J Am Coll Cardiol; 2012 Sep; 60(10):898-907. PubMed ID: 22703928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.
    Kardia SL; Kelly RJ; Keddache MA; Aronow BJ; Grabowski GA; Hahn HS; Case KL; Wagoner LE; Dorn GW; Liggett SB
    BMC Med Genet; 2008 Oct; 9():93. PubMed ID: 18947427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction.
    Lymperopoulos A; Negussie S; Walklett K
    Pharmacogenomics; 2013 Oct; 14(13):1545-9. PubMed ID: 24088125
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
    Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
    Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of adrenergic receptors and the risk of heart failure.
    Maitland ML; Gomberg-Maitland M
    N Engl J Med; 2003 Jan; 348(5):468-70; author reply 468-70. PubMed ID: 12557866
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymorphisms of adrenergic receptors and the risk of heart failure.
    Meisel C; Köpke K; Roots I
    N Engl J Med; 2003 Jan; 348(5):468-70; author reply 468-70. PubMed ID: 12556550
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT.
    Johnson AE; Hanley-Yanez K; Yancy CW; Taylor AL; Feldman AM; McNamara DM
    J Card Fail; 2019 Jul; 25(7):553-560. PubMed ID: 30978507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta1- and alpha2c-adrenoreceptor variants as predictors of clinical aspects of dilated cardiomyopathy in people of African ancestry.
    Woodiwiss AJ; Badenhorst D; Sliwa K; Brooksbank R; Essop R; Sareli P; Norton GR
    Cardiovasc J Afr; 2008; 19(4):188-93. PubMed ID: 18776959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Genetic Polymorphisms in the Beta-1 Adrenergic Receptor with Recovery of Left Ventricular Ejection Fraction in Patients with Heart Failure.
    Luzum JA; English JD; Ahmad US; Sun JW; Canan BD; Sadee W; Kitzmiller JP; Binkley PF
    J Cardiovasc Transl Res; 2019 Aug; 12(4):280-289. PubMed ID: 30756358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
    Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
    Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.